Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 2Phase EARLY_PHASE1 1Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Sleep Apnea, Obstructive 1Sarcoma 1Rhinitis, Allergic, Seasonal 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Mesothelioma 1Lung Neoplasms 1Lung Diseases, Interstitial 1Kidney Neoplasms 1Hypertension, Pulmonary 1Emphysema 1Cystic Fibrosis 1Bronchiectasis 1Breast Neoplasms 1Asthma 1Asbestosis 1

Interventions

Letrozole 7Fluorodeoxyglucose F18 7Magnetic Resonance Spectroscopy 5Blood Specimen Collection 5pembrolizumab 4atezolizumab 4Trastuzumab 4Oncolytic Virotherapy 4Bevacizumab 4palbociclib 3Saline Solution 3Fish Oils 3Docosahexaenoic Acids 3Denosumab 3Carboplatin 3Biopsy 3pertuzumab 2olaparib 2Vitamin D 2Vinorelbine 2Taxes 2Sentinel Lymph Node Biopsy 2Radiotherapy 2Positron-Emission Tomography 2Positron Emission Tomography Computed Tomography 2Paclitaxel 2Omacor 2Neoadjuvant Therapy 2Metformin 2Lapatinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Breast Neoplasms × perflutren × Clear all
NCT04721886 2026-04-02

Contrast-Enhanced Ultrasound Scan for the Estimation of Tissue Pressure in Patients With Breast Cancer

Thomas Jefferson University

Phase EARLY_PHASE1 Completed
25 enrolled 8 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡